# To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients

> **NCT05369650** · NA · UNKNOWN · sponsor: **West China Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** Lidocaine Hydrochloride, Injectable

## Key facts

- **NCT ID:** NCT05369650
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-27
- **Primary completion:** 2022-05-27
- **Final completion:** 2022-09-27
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369650, "To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05369650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*